- Research
- Published:
The silent struggle: assessing anxiety prevalence in Marrakech鈥檚 hypertensive population
樱花视频 volume听25, Article听number:听1179 (2025)
Abstract
Background
Anxiety is a disorder that may negatively impact the quality of life for people with hypertension. In Marrakech, epidemiological data on anxiety in hypertension patients are scarce, preventing holistic treatment for hypertensive patients and favoring the development of comorbidities. This study aims to assess the prevalence of self-reported anxiety among hypertensive patients receiving care in primary healthcare centers in Marrakech.
Methods
Between May 2021 and December 2022, a cross-sectional study of 1053 hypertensive patients who visited primary healthcare centers in Marrakech was carried out. Socio-demographic information, behavioral and clinical information, hypertensive treatment characteristics, and the care-patient-physician triad were all collected via a face-to-face questionnaire. The Generalized Anxiety Disorder Scale (GAD-7) was used to assess self-reported anxiety. Multivariate logistic regression was used to identify risk factors for self-reported anxiety.
Results
A total of 348 (33.1%) of those with hypertension overall reported having anxiety symptoms. 301 (86.5%) patients were females, and the mean age was 61.5鈥壜扁€�9.6 years (mean鈥壜扁€塻tandard deviation). High stress, moderate stress, family history of hypertension, pain and physical discomfort, non-purchase of drug if it is out of stock at the primary healthcare centers, living in urban areas, lack of social support, and non-consumption of five fruits and vegetables per day were identified as risk factors of self-reported anxiety.
Conclusion
Self-reported anxiety is prevalent in one third of hypertensive patients in Marrakech. Hence, greater emphasis should be placed on the mental health component when managing hypertensive patients in primary healthcare centers.
Introduction
Hypertension is a public health issue and a risk factor for non-communicable illnesses afflicting 1.28听billion people worldwide. 82.0% of them reside in low- and middle-income countries [1]. Each year, hypertension causes nine million premature deaths in the world [2]. In Morocco, the prevalence of non-communicable illnesses has grown as a result of demographic change, urbanization, and a sedentary lifestyle. According to the most current stepwise research on risk factors for noncommunicable diseases, which included 5429 persons aged 18 and older, the prevalence of hypertension was 29.3% in 2018 [3]. The Ministry of Health and Social Protection is implementing a program to prevent and control hypertension since 1996 in an effort to lower premature mortality, morbidity, and incapacitating conditions caused by hypertension. Over 1.28听million hypertensive individuals received treatment in 2021, while a total of 89,786 people received a diagnosis at primary healthcare centers [4].
Mental disorders are also a public health problem, with a prevalence of 7.3% worldwide [5]. In Morocco, this prevalence was 9% [6]. Anxiety is defined by the World Health Organization (WHO) as the feeling of imminent and indeterminate danger accompanied by uneasiness, agitation, helplessness, or even annihilation [7, 8]. Several studies have reported a positive association between high blood pressure and anxiety. Indeed, in 2015, an association between hypertension and self-reported anxiety was described in a systematic review of 13 studies [9, 10]. Demographic characteristics such as age [11], sex [12], environmental characteristics such as exposure to traffic noise [13], and behavioral characteristics such as sedentary lifestyle, smoking, and alcohol abuse were the main risk factors associated with comorbid hypertension and anxiety [14, 15].
Failure to screen for anxiety in hypertensive patients can have negative impacts on their treatment. It can promote non-adherence to antihypertensive drugs, to dietary rules, and to medical monitoring, and even lead to uncontrolled blood pressure and complications [16]. Anxiety can even impair a patient鈥檚 quality of life [17], and increase healthcare costs [18].
To better direct public policies for the prevention and treatment of hypertension, knowledge of the prevalence of anxiety in hypertensive patients and its risk factors is crucial. Therefore, the aim of our study was to determine the prevalence of self-reported anxiety among hypertensive patients monitored at Marrakech鈥檚 primary healthcare centers.
Methods
We carried out cross-sectional research between the 26th of May 2021 and the 30th December of 2022. The study included hypertensive patients monitored at primary healthcare centers. We used a two-stage sampling method. The primary unit was made up of primary healthcare centers. The secondary unit consisted of hypertensive patient aged 18 years or older who had been on pharmacological therapy for hypertension for at least six months, were monitored at primary healthcare centers in Marrakech, and provided their consent to participate in the study. Pregnant women were not included in the study.
Sample size and data collection tool
We determined the sample size based on a 50% estimated prevalence of self-reported anxiety, a 95% confidence range, a 5% margin of error, a 20% non-response rate, and a cluster effect of two. The required patient number was 922.
We used a standardized questionnaire administered face-to-face to gather information on sociodemographic and economic factors, behavioral and clinical traits, antihypertensive treatment characteristics, and the relationship between patients, the healthcare system, and the doctor.
The socio-demographic and economic data included: age in years, sex (female or male), area of residence (urban or rural), marital status (single or partnered), education (can read and write or can neither read nor write), occupation (with or without), monthly income (less than 150 dollars, between 150 and 199 dollars, between 200 and 299 dollars, between 300 and 499 dollars, and more than or equal to 500 dollars), and health insurance (yes or no).
Operational definition
Self-reported anxiety assessment: the Generalized Anxiety Disorders-7 (GAD-7) was used to assess self-reported anxiety in hypertensive patients. The GAD-7 consists of seven questions to which patients respond by 鈥渘ever鈥�, 鈥渟everal days鈥�, 鈥渕ore than half the days鈥� and 鈥渁lmost every day鈥�. The following questions were asked: Over the last two weeks, how often have you been bothered by the following problems: (i) Feeling nervous, anxious, or on edge?; (ii) Unable to stop or control worrying?; (iii) Worrying excessively about several things?; (iv) Having trouble relaxing?; (v) Being so restless that it is hard to sit still?; (vi) Getting quickly irritated or upset?; (vii) Fearing that something terrible could occur?. Each question was scored on a scale of zero to three. zero for 鈥渘ever鈥�, one for 鈥渟everal days鈥�, two for 鈥渕ore than half the days鈥� and three for 鈥渁lmost every day鈥�. The sub-scores of the seven questions were put together to yield a total score that ranged from 0 to 21. The following is how the score was interpreted: A score of 0 to 4 indicated no symptoms; a score of 5 to 9 indicated mild symptoms; a score of 10 to 14 indicated moderate symptoms; and a score of 15 to 21 indicated severe symptoms. People who received a score of 5 or higher were deemed to have self-reported anxiety [19, 20].
Blood pressure: An electronic sphygmomanometer with an adjustable cuff (Micro Life Pro M with a 3-mmHg accuracy) was used for measuring blood pressure. We referred to the European Society of Arterial Hypertension and the European Society of Cardiology (ESH/ESC) guidelines for blood pressure regulation to identify hypertensive patients [21].
We utilized a digital scale (with an accuracy of 100听g) to measure the body weight of barefoot patients in little clothes. We used a measuring rod to determine the height. The patients stood, barefoot, feet together, arms at their sides, at attention [22]. Overweight and obesity were determined using WHO guidelines [23].
We determined the existence of social support by asking participants if they received social support.
We reported physical pain or discomfort by asking participants if they had chest pain, lower back pain, headaches, or any other signs that produced pain or discomfort.
We reported the presence of reduced mobility by asking participants if they had difficulty going around on foot.
We reported a lack of autonomy by asking participants if they had difficulty taking care of themselves (like if they could dress or wash themselves).
We assessed the healthcare system鈥檚 relationship with patients by asking the following questions: (i) How far is it from your home to the primary healthcare center?; (ii) How long does it take you to go to the primary healthcare center?; (iii) Which kind of transport do you use when going to the primary healthcare center? If the distance between the participants鈥� home and the primary healthcare center is greater than or equal to 6听km and the time required to get to the primary healthcare center is greater than or equal to 30听min, and the participants need to go via a mode of transport, we reported unsatisfactory relationship with the healthcare system.
Statistical analysis
All data were imported into Excel and analyzed using Epi-Info-7. To describe continuous variables, the mean and standard deviation were used. For categorical variables, we used numbers and percentages. The Pearson chi-square test or, where applicable, Fisher鈥檚 exact test were used to compare categorical variables. The analysis of variance (ANOVA) or Mann-Whitney tests were used to compare continuous variables, if appropriate. In the multiple logistic regression, we included all variables with a p-value less than 0.20 in the bivariate analysis. The adjusted odds ratio (AOR) and its 95% confidence interval were used to assess the association between the risk factor and the presence of self-reported anxiety.
Results
Demographic and socioeconomic characteristics
The demographic and socio-economic characteristics of hypertensive patients are summarized in Table听1. A total of 1053 patients were approached, with a prevalence of 33.1% self-reported anxiety. The average age of the patients was 63,0鈥壜扁€�09.9 years; 811 (77.0%) were female; and 300 (28.5%) had a monthly family income of less than $150.
Behavioral characteristics
Table听2 summarizes those 101 hypertensive patients (09.6%) were tobacco users, 47 (04.5%) were alcohol consumers, 937 (89.0%) had stress, 746 (70.8%) had insufficient physical activity, 669 (63.5%) were sedentary, 567 (53.8%) did not eat five fruits and vegetables per day, and 367 (34.8%) stated that they did not benefit from social support.
Clinical characteristics
According to Tables听3 and 508 (48.2%) of hypertensive patients had a comorbidity, 458 (43.5%) had diabetes, 499 (47.4%) had a duration of hypertension greater than or equal to five years, 601 (57.1%) had a family history of hypertension, 79 (07.5%) had reduced autonomy, 587 (55.8%) experienced pain and physical discomfort, and 843 (80.1%) were overweight or obese.
Characteristics of the care-patient-doctor system and antihypertensive drug
Amongst 1053 participants, 873 (82.9%) had a bad relationship with the healthcare system, 507 (48.1%) didn鈥檛 think their doctor was willing to pay attention to their questions about their sickness, 637 (60.5%) reported antihypertensive drug non-availability at the primary healthcare center, 263 (25.0%) reported adverse effects from the antihypertensive drug, and 252 (23.9%) reported not buying antihypertensive drug in case of stockout at the primary healthcare centers 鈥淭able听4鈥�.
Self-reported anxiety
Self-reported anxiety was reported by 348 (33.1%) participants. Table听1 shows that they were 61.5鈥壜扁€�9.6 years old on average, 301 (86.5%) were females, and 290 (83.3%) resided in cities. According to an examination of behavioral and clinical data, 339 (32.2%) were stressed, and 180 (51.7%) stated that they had not benefited from social support 鈥淭able听2鈥�. A total of 248 (71.3%) had a family history of hypertension, 240 (69.0%) had pain or physical discomfort 鈥淭able听3鈥�, and 133 (38.2%) did not buy drug if there was a supply deficit in primary healthcare centers 鈥淭able听4鈥�. Ten (0.9%) individuals experienced severe anxiety, 65 (06.2%) mild anxiety, 273 (25.9%) light anxiety, and 705 (67.0%) had no anxiety symptoms.
During the bivariate analysis, the p-value was set at 0.20. As mentioned in 鈥淭able听5鈥�, after bivariate analysis, 26 factors were associated with the presence of self-reported anxiety: (i) female sex; (ii) age; (iii) urban area; (iv) low monthly income; (v) tobacco consumption; (vi) alcohol consumption; (vii) stress; (viii) sedentary; (ix) non-consumption of five fruits and vegetables per day; (x) lack of self-monitoring of hypertension; (xi) lack of social support; (xii) presence of comorbidity; (xiii) presence of diabetes; (ivx) duration of hypertension greater than five years; (xv) family history of hypertension; (xvi) lack of autonomy; (xvii) pain and physical discomfort; (xviii) reduced mobility; (ixx) overweight or obesity; (xx) unsatisfactory relationship between the patient and the healthcare system; (xxi) patients鈥� perception of their doctor鈥檚 lack of willingness to understand their concerns regarding their hypertension; (xxii) availability of the drug; (xxiii) non-purchase of drug if it is out of stock at the primary healthcare centers; (ivxx) perception by the patient of having too much drug to take; (xxv) perception that the drug has more adverse effects than benefits; and (xxvi) unsatisfactory physical activity 鈥淭able听5鈥�.
Multivariate analysis
After controlling for other variables, we identified the following factors to be associated with self-reported anxiety in hypertensive patients: (i) high stress compared to low stress (Adjusted Odd Ratio of 12.4; CI [5.66鈥�27.2]); (ii) moderate stress compared to low stress (AOR of 2.4; CI [1.12鈥�5.12]); (iii) family history of hypertension (AOR of 2.2; CI [1.58鈥�3.13]); (iv) pain and physical discomfort (AOR of 1.8; CI [1.41鈥�2.48]); (v) non-purchase of drug if it is out of stock at the primary healthcare centers (AOR of 1.8; CI [1.27鈥�2.76]); (vi) urban area (AOR of 1.8; CI [1.11鈥�2.87]); (vii) lack of social support (AOR of 1.6; CI [1.17鈥�2.35]); and (viii) non-consumption of five fruits and vegetables per day (AOR of 1.4; CI [1.01鈥�1.97]) 鈥淭able听5鈥�.
Discussion
To our knowledge, this is the first study in Morocco assessing the prevalence of self-reported anxiety in patients with hypertension followed at primary healthcare centers. Previous surveys carried out by our research team had dealt with uncontrol of high blood pressure and non-adherence to antihypertensive treatment without focusing on mental problems [24,25,26]. The national survey conducted in 2005 among the general population had shown a prevalence of self-reported anxiety of 9% [6]. In this study, among hypertensive patients, the frequency of self-reported anxiety was 33.1%, whereas it was 55.3% in a sample of 152 hypertensive patients in Brazil [27], 32.7% in a sample of 471 in Ethiopia [28], 23.1% in a sample of 322 in Nigeria [29], 21.7% in Russia, in a sample of 2775 hypertensive patients [30], 12.3% in China, in a sample of 4993 hypertensive patients [31], and 11.6% in Zhejiang in a sample of 891 hypertensive patients [9]. These disparities in frequency between countries might be attributed to the sample size and the heterogeneity of the techniques employed to assess self-reported anxiety. Hormonal differences between the sexes, psychosocial factors associated with feminine ideas of gender, and how parents interact with their baby at birth, depending on whether he is a boy or a girl, all influence how adults perceive their anxiety symptoms, putting women at a higher risk than men [32, 33]. Female sex was not associated with self-reported anxiety in our study.
Pogosova et al. link stress to self-reported anxiety; a similar finding was found in our study [30].
Low monthly household income, recurrent stock-outs of antihypertensive drugs at primary healthcare centers, financial difficulties in purchasing these drugs from pharmacies, complications from hypertension, and a lack of social support could explain this association. Moreover, the unsatisfactory relationship between the patient, the healthcare system, and the nursing staff is also contributing to the anxiogenic symptoms.
In this study, having a family history of hypertension was linked to self-reported anxiety. This might be explained by the illness鈥檚 potential consequences, negative familial experiences with hypertension, and the patient鈥檚 refusal to recognize the diagnosis.
In our study, living in an urban area was associated with self-reported anxiety. The 2023 study, done in the United Kingdom with 156,075 participants, found a significant association between self-reported anxiety and living in an urban area [34]. This could be associated with the high population density, pollution and noise, and the quick pace of life. It could also be explained by the social isolation that comes with anonymity in big cities.
Pain and physical discomfort in hypertensives could occur and lead to feelings of worthlessness and helplessness, low self-esteem, and increased in negative thoughts related to fears from complications from hypertension. Fear of pain during physical movement can lead to avoidance behavior that makes hypertensive patients more susceptible to anxiety. In our study, pain and physical discomfort were associated with self-reported anxiety.
Low monthly income per household, high cost of antihypertensive drugs, food inflation following the COVID-19 pandemic, the need to meet the basic needs of all family members at the expense of one鈥檚 own drug needs, and fear of developing complications are all elements that may explain the relationship between self-reported anxiety and non-purchase of antihypertensive drugs when out of stock in primary healthcare settings.
According to Strep de Vries et al., the presence of greenery causes a decrease in anxiety and a rise in feelings of well-being. It would result in a reduction in mental tiredness and a greater ability to recuperate from stress [35]. Indeed, interaction with nature stimulates people to engage in healthy activities such as physical activity and reduces the prevalence of worry. According to the scientific literature, vegetation has a psychological influence on human health. This evolutionary hypothesis supports the notion that the human species鈥� two million years of development in the natural environment would have left biological and genetic marks. And that any visual contact with the natural world, whether it be plants or water, will elicit a sense of security and well-being. The paucity of green space in metropolitan areas might explain the link between self-reported anxiety and the urban living environment in our study [36].
People鈥檚 mental health is influenced by social support through the effects it has on their emotions, cognition, and actions. As a result, the social network can influence a person鈥檚 behaviors and daily activities, such as sports and eating habits, as well as the development of positive psychological states such as a sense of belonging, security, stability, and a recognition of one鈥檚 value. The social network may also provide important information to stimulate the adoption of healthy behaviors as well as physical or financial assistance to increase overall well-being. Integration into a social network is important for all of these reasons because it lessens feelings of despondency [37], increases motivation to take care of oneself and enhances immunological functions while increasing endocrine system processes. In our research, a lack of social support was linked to self-reported anxiety.
Because of their vitamin and mineral content, vegetables, fruits, and plant ingredients may be anxiolytics [38], as may be other formulations containing a diverse spectrum of micronutrients [39]. These micronutrients, which include zinc and selenium, function as coenzymes in the production and regulation of neurotransmitters and neurotrophic factors [40,41,42] which may explain their role in mental well-being. Non-consumption of five fruits and vegetables per day was linked to self-reported anxiety in hypertensive patients in our study.
Our study has some limitations, such as social desirability bias encountered in collecting data on cigarette and alcohol consumption, as well as intentional lying bias in collecting data on monthly income. The patient鈥檚 declarations served as the basis for measuring social support. Future study should consider using more robust and accurate measurement methods, such as the Cohen and Wills social support scale.
Our study seems to have a selection bias; however, the female population鈥檚 predominance could be explained by the nature of the health programs given in primary health care facilities, which are primarily concerned with maternity and child health. It could also be explained by the fact that women prioritize their health more than males.
Conclusion
Anxiety symptoms are present in hypertensive patients, which might affect the blood pressure reading and accordingly their management care and their quality of life. Risk factors such as stress, a family history of hypertension, physical pain and discomfort, not purchasing antihypertensive medication when it was out of stock at primary healthcare centers, a lack of social support, and not eating five fruits and vegetables per day were associated with the presence of self-reported anxiety.
Treating physicians should assess the presence of these risk factors, and regularly screen hypertensive patients for anxiety throughout their medical follow-up in order to ensure holistic medical care and be able to reduce complications linked to hypertension and improve the quality of life of hypertensive patients. Other similar studies should be carried out in other regions to confirm our results and be able to establish a causal link.
Data availability
All data generated or analyzed during this study are included in this published article.
References
Nations-Unies. Plus de 700 millions de personnes souffrent d鈥檋ypertension non trait茅e (OMS)| ONU Info. [cited 13 Jul 2023]. Available:
Maladies cardiovasculaires. [cited 26 Jul 2023]. Available: ).
Minist猫re de la sant茅 Maroc. Enqu锚te nationale sur les facteurs de risque des maladies non transmissibles. 2019. [cited 13 Jul 2023]. Available:
Minist猫re de la Sant茅 M. Sant茅 en chiffres. 2021 [cited 13 Jul 2023]. Available:
Craske MG, Stein MB, Anxiety. Lancet. 2016;388:3048鈥�59. .
Moussaoui D. La Sant茅 mentale Au Maroc: enqu锚te Nationale Sur La pr茅valence des troubles mentaux et des toxicomanies. Encephale. 2007;33. .
World Health Organization. Monitoring mental health systems and services in the WHO European Region: Mental Health Atlas. 2017. 2019.
Essayagh F, Essayagh M, Essayagh S, Marc I, Bukassa G, El otmani I, et al. The prevalence and risk factors for anxiety and depression symptoms among migrants in Morocco. Sci Rep. 2023;13. .
Pan Y, Cai W, Cheng Q, Dong W, An T, Yan J. Association between anxiety and hypertension: a systematic review and meta-analysis of epidemiological studies. Neuropsychiatr Dis Treat. 2015;11:1121. .
Hamrah MS, Hamrah MH, Ishii H, Suzuki S, Hamrah MH, Hamrah AE, et al. Anxiety and depression among hypertensive outpatients in Afghanistan: A Cross-Sectional study in Andkhoy City. Int J Hypertens. 2018;2018. .
van Rijssel AE, Stins BC, Beishon LC, Sanders ML, Quinn TJ, Claassen JAHR, et al. Effect of antihypertensive treatment on cerebral blood flow in older adults: a systematic review and Meta-Analysis. Hypertension. 2022;79. .
Sabbatini AR, Kararigas G. Estrogen-related mechanisms in sex differences of hypertension and target organ damage. Biology Sex Differences. 2020. .
Kupcikova Z, Fecht D, Ramakrishnan R, Clark C, Cai YS. Road traffic noise and cardiovascular disease risk factors in UK biobank. Eur Heart J. 2021;42. .
Qiu T, Jiang Z, Chen X, Dai Y, Zhao H. Comorbidity of anxiety and hypertension: common risk factors and potential mechanisms. Int J Hypertens. 2023. .
Essayagh F, Essayagh T, Essayagh M, Khouchoua M, Lemriss H, Rattal M, et al. Disease burden among migrants in Morocco in 2021: A cross-sectional study. PLoS ONE. 2023;18. .
Li H, Ge S, Greene B, Dunbar-Jacob J. Depression in the context of chronic diseases in the united States and China. Int J Nurs Sci. 2019. .
Wu P, Li L, Sun W. Influence factors of depression in elderly patients with chronic diseases. Biomedical Res (India). 2018;29. .
Wallace K, Zhao X, Misra R, Sambamoorthi U. The humanistic and economic burden associated with anxiety and depression among adults with comorbid diabetes and hypertension. J Diabetes Res. 2018;2018. .
Spitzer RL, Kroenke K, Williams JBW, L枚we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092鈥�7. .
Essayagh F, Essayagh M, Lambaki A, Naji AA, Essayagh S, Essayagh T. Determinants associated with low dietary diversity among migrants to Morocco: a cross sectional study. Sci Rep 2024. 2024;14:1. .
Mancia G, Fagard R, Narkiewicz K, Red贸n J, Zanchetti A, B枚hm M, et al. 2013 Practice guidelines for the management of arterial hypertension of the European society ofhypertension (ESH) and the European society of cardiology (ESC): ESH/ESCTask force for the management of arterial hypertension. Journal of hypertension. Lippincott Williams and Wilkins; 2013. pp. 1925鈥�38. .
Belayachi S, Boukhari FZ, Essayagh F, Terkiba O, Marc I, Lambaki A, et al. Uncontrolled blood pressure and its risk factors among hypertensive patients. Marrakech Morocco Sci Rep 2024. 2024;14:1. .
Principaux rep猫res sur l鈥檕b茅sit茅. et le surpoids. [cited 29 Jan 2025]. Available:
Essayagh T, Essayagh M, Rhaffouli AE, Khouchoua M, Kazadi GB, Khattabi A, et al. Prevalence of uncontrolled blood pressure in Meknes, Morocco, and its associated risk factors in 2017. PLoS ONE. 2019;14. .
Essayagh M, Essayagh T, Essayagh S. Drug non-adherence in hypertensive patients in Morocco, and its associated risk factors. Eur J Cardiovasc Nurs. 2020. .
Belayachi S, Boukhari FZ, Essayagh F, Terkiba O, Zohoun A, Essayagh M, et al. Non-adherence to antihypertensive drugs and its risk factors among hypertensive patients, Marrakech, Morocco. PLOS Global Public Health. 2024;4:e0002774. .
Saboya PMHP, Zimmermann PR, Bodanese LC. Association between anxiety or depressive symptoms and arterial hypertension, and their impact on the quality of life. Int J Psychiatry Med. 2010;40:307鈥�20. .
Abdisa L, Letta S, Nigussie K. Depression and anxiety among people with hypertension on follow-up in Eastern Ethiopia: A multi-center cross-sectional study. Front Psychiatry. 2022;13:853551. .
Amaike C, Salami OF, Bamidele OT, Ojo AM, Otaigbe I, Abiodun O, et al. Association of depression and anxiety with uncontrolled hypertension: A cross-sectional study in Southwest Nigeria. Indian J Psychiatry. 2024;66:157. .
Pogosova N, Boytsov S, Bacquer D, De, Sokolova O, Ausheva A, Kursakov A, et al. Factors associated with anxiety and depressive symptoms in 2775 patients with arterial hypertension and coronary heart disease: results from the COMETA multicenter study. Glob Heart. 2021;16:73. .
Ma H, Zhao M, Liu Y, Wei P. Network analysis of depression and anxiety symptoms and their associations with life satisfaction among Chinese hypertensive older adults: a cross-sectional study. Front Public Health. 2024;12:1370359. .
Pavlidi P, Kokras N, Dalla C. Sex differences in depression and anxiety. Curr Top Behav Neurosci. 2023;62:103鈥�32. .
Qiu T, Jiang Z, Chen X, Dai Y, Zhao H. Comorbidity of anxiety and hypertension: common risk factors and potential mechanisms. Int J Hypertens. 2023;2023. .
Xu J, Liu N, Polemiti E, Garcia-Mondragon L, Tang J, Liu X, et al. Effects of urban living environments on mental health in adults. Nat Med 2023. 2023;29:6. .
de Vries S, Verheij RA, Groenewegen PP, Spreeuwenberg P. Natural environments - healthy environments? An exploratory analysis of the relationship between greenspace and health. Environ Plan A. 2003;35:1717鈥�31. .
Ulrich RS. View through a window May influence recovery from surgery. Sci (1979). 1984;224. .
Thoits PA. Social support and psychological Well-Being: theoretical possibilities. Social Support: Theory Res Appl. 1985;51鈥�72. .
Zhu F, Du B, Xu B. Anti-inflammatory effects of phytochemicals from fruits, vegetables, and food legumes: A review. 2017;58: 1260鈥�70. .
Alusik S, Kalatova D, Paluch Z. Serotonin syndrome. Neuroendocrinol Lett. 2014. .
Aucoin M, Lachance L, Naidoo U, Remy D, Shekdar T, Sayar N, et al. Diet and anxiety: A scoping review. Nutrients. 2021;13. .
Solomons NW. Dietary Sources of Zinc and Factors Affecting its Bioavailability. 2001;22: 138鈥�54.
Rucklidge JJ, Kaplan BJ. Broad-spectrum micronutrient formulas for the treatment of psychiatric symptoms: a systematic review. Expert Rev Neurother. 2013;13:49鈥�73. .
Acknowledgements
Not applicable.
Funding
No funding is applicable.
Author information
Authors and Affiliations
Contributions
F.Z.B., S.B., F.E., M.E., S.E., and T.E.: Conceptualization, methodology, investigation, analysis, project administration, validation, and writing original draftA.A.N., H.L., K.A.: writing original draft.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The ethics committee of Rabat鈥檚 Faculty of Medicine and Pharmacy reviewed and approved the study (#21/21). The study was conducted according to with the Helsinki Declaration. After being informed about the aim of the study and the respect and confidentiality of personal privacy, all participants provided an informed written statement of consent.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher鈥檚 note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article鈥檚 Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article鈥檚 Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit .
About this article
Cite this article
Boukhari, F.Z., Belayachi, S., Essayagh, F. et al. The silent struggle: assessing anxiety prevalence in Marrakech鈥檚 hypertensive population. 樱花视频 25, 1179 (2025). https://doi.org/10.1186/s12889-025-22459-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12889-025-22459-z